Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARCH: Maraviroc Switch Study in HIV-1
NCT01384682Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Aug 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by The Kirby Institute. Started Aug 2011; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01384682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384682.